Ruxolitinib Cream in Pakistan

Ruxolitinib Cream in Pakistan

Ruxolitinib cream is a topical JAK inhibitor approved for treating non-segmental vitiligo. It helps Repigmentation  skin by reducing immune-driven inflammation and promoting melanocyte regeneration. In patients who are unable to use other medications for their condition or whose eczema has not responded to another medication, topical ruxolitinib is used to treat the symptoms of eczema (atopic dermatitis), a skin disease that causes the skin to be dry and itchy and occasionally develop red, scaly rashes.

Key Benefits:

Helps treat vitiligo (loss of skin pigment)
Effective for atopic dermatitis (eczema)
Reduces skin inflammation and redness
Helps restore natural skin color over time
Dermatologist-recommended treatment

How It Works:

Opzelura works by blocking specific enzymes (JAK1 and JAK2) involved in overactive immune responses and skin inflammation. This helps reduce redness, itch, rash, and immune-mediated pigment loss, supporting skin healing and potential repigmentation over time.

How To Use:

For topical application only — apply a thin layer to affected areas as directed by your healthcare provider.